New Icon collab looks to meet demand for real world evidence
Icon and Practice Fusion have teamed up to meet the expanding demand for real world evidence – and aim to transform the way research is conducted.
Archives for August 9, 2018
Certara outlines the role of quantitative systems pharmacology in FIH trial design, EMA responds
Modeling and simulation can provide “meaningful prediction” of a drug’s pharmacodynamic range and maximum dose – the use of which might have prevented the tragic outcome of the BIAL 10-2474 trial in 2016, says Certara VP.
CRISPR research deal will attract new business, says Oxford Genetics
Oxford Genetics has signed a supply and licensing agreement for CRISPR engineered mammalian cell line with an unnamed ecommerce firm.
EU export manufacturing waiver a threat to innovation, says IPHA
The IPHA has spoken out against a proposed export manufacturing waiver, which it says threatens manufacturing innovation across Europe.
SI Group increases ibuprofen manufacture by 35% amid global shortage
SI Group announced that it will be increasing its capacity for ibuprofen manufacture by 25%, to be completed by 2020.
Medpace surprises with Q2 2018 revenue growth: ‘Things have been running very smoothly’
Revenue growth has taken off, driven by steady start-up on several programs, as the CRO remains focused on its core market of small and midsized biopharma – which makes up the majority of its revenue.
Frequency sounds out progenitor cell activation for hearing restoration
Frequency Therapeutics initiates a Phase I/II clinical trial for hearing restoration, using progenitor cell activator technology for the first time in adult patients.